Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals
Back to resultsA-Z list

Medication reference

Droperidol

Monograph awaiting updateThis monograph will be updated in the future.

Jump to a section
Search DailyMed products (opens in a new tab)

Historical source. Current clinical review is incomplete. This monograph will be updated in the future.

Inapsine ® - Droperidol (opens in a new tab)Original source URL: https://globalrph.com/dilution/inapsine-droperidol/ | Retrieved 2026-11-04

Source dates, location and integrity

This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.

Original source URL
https://globalrph.com/dilution/inapsine-droperidol/ (opens in a new tab)
Source date
Not established in the retrieved source
Retrieved
2026-11-04T19:49:20.485708+00:00
Source location
div.post-content
Packaged content SHA-256
e9850093070842687645b01eaa64580b146f06def2be92b86870dd22c8a7f416
Original response SHA-256
24b1e0fb03567de3e9385fb1649d3edec70241e9a14bde4c853d3aaf149a374f
Source body SHA-256
2198f3a89f633c79da41f6c97954159d0707f032030fa779ca210fa25a958bd5

Droperidol (Inapsine ® )
The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.

Usual Diluents
D5W, NS

Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate]
[1 to 3 mg/ 50 ml] [30 min]
[4 to 10 mg/ 100 ml] [As directed]

------Continuous infusion------
[25 mg/ 500 ml] [As directed]

Stability / Miscellaneous

Stability data:
Drug Stability
Refrigerated		 Stability
Room Temp.		 Reconstituted
Vial/Powder		 Notes
Droperidol - Inapsine Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). Solution Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If such abnormalities are observed, the drug should not be administered.

Protect from light. Retain in carton until time of use.


Label: Do not Refrigerate.
Actions: Marked sedation/ antiemetic.

WARNING
Cases of QT prolongation and/or torsade de pointes have been reported in patients receiving droperidol at doses at or below recommended doses. Some cases have occurred in patients with no known risk factors for QT prolongation and some cases have been fatal.

Due to its potential for serious proarrhythmic effects and death, droperidol should be reserved for use in the treatment of patients who fail to show an acceptable response to other adequate treatments, either because of insufficient effectiveness or the inability to achieve an effective dose due to intolerable adverse effects from those drugs (see Warnings, Adverse Reactions, Contraindications, and Precautions).

Cases of QT prolongation and serious arrhythmias (e.g., torsade de pointes) have been reported in patients treated with droperidol. Based on these reports, all patients should undergo a 12-lead ECG prior to administration of droperidol to determine if a prolonged QT interval (i.e., QTc greater than 440 msec for males or 450 msec for females) is present. If there is a prolonged QT interval, droperidol should NOT be administered. For patients in whom the potential benefit of droperidol treatment is felt to outweigh the risks of potentially serious arrhythmias, ECG monitoring should be performed prior to treatment and continued for 2-3 hours after completing treatment to monitor for arrhythmias.

Droperidol is contraindicated in patients with known or suspected QT prolongation, including patients with congenital long QT syndrome.

Droperidol should be administered with extreme caution to patients who may be at risk for development of prolonged QT syndrome (e.g., congestive heart failure, bradycardia, use of a diuretic, cardiac hypertrophy, hypokalemia, hypomagnesemia, or administration of other drugs known to increase the QT interval). Other risk factors may include age over 65 years, alcohol abuse, and use of agents such as benzodiazepines, volatile anesthetics, and I.V. opiates. Droperidol should be initiated at a low dose and adjusted upward, with caution, as needed to achieve the desired effect.

DOSAGE AND ADMINISTRATION
Dosage should be individualized. Some of the factors to be considered in determining dose are age, body weight, physical status, underlying pathological condition, use of other drugs, the type of anesthesia to be used, and the surgical procedure involved.

Vital signs and ECG should be monitored routinely.

Adult Dosage: The maximum recommended initial dose of droperidol is 2.5 mg I.M. or slow I.V. Additional 1.25 mg doses of droperidol may be administered to achieve the desired effect. However, additional doses should be administered with caution, and only if the potential benefit outweighs the potential risk.

Pediatric Dosage: For children two to 12 years of age, the maximum recommended initial dose is 0.1 mg/kg, taking into account the patient's age and other clinical factors. However, additional doses should be administered with caution, and only if the potential benefit outweighs the potential risk.

See WARNINGS for use of droperidol with other CNS depressants and in patients with altered response.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If such abnormalities are observed, the drug should not be administered.

Premedication: 2.5 to 10mg IV / IM. Usually 1.25 to 2.5 mg q3-6h prn.

Continuous infusion: 25 mg/500 ml D5W at 1 mg/hr initially for treatment of hyperemesis gravidarum (give 1 to 2.5 mg loading initially). May increase by 0.25 mg at 4hr intervals if patient not responding (usual range: 1 to 1.25 mg/hr). Also add benadryl 50mg q6h until infusion is stopped. When patient is ready to take oral meds switch to reglan 10mg qid + hydroxyzine 50mg.

HOW SUPPLIED
Droperidol Injection, USP 2.5 mg/mL is supplied in 2 mL (5 mg) single-dose ampuls packaged in cartons of ten (List No. 1187).

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]
Protect from light.

©Hospira 2004
EN-0531
HOSPIRA, INC., LAKE FOREST, IL 60045 USA

Source: [package insert]:

Open this historical article on its own

Product identifiers and clinical review status

This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.

Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.

What remains to be completed
  • Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
  • Clinically reviewed, individually identified statements with two exact source mappings
  • Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
  • Renal-function methods and dialysis/CRRT modality review where applicable
  • Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation

Supplemental historical fields

Restored-data provenance and review notes

Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.

Current review annotations for historical renal, dialysis, mechanism, and product fieldsSeparate renal reference: Open Renal Dosing Master (opens in a new tab)
Renal
Status
not_locally_normalized
Original classification
current_label_review_required
Entries
    General note
    Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
    Dialysis
    Status
    no_local_structured_regimen
    Entries
      General note
      Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
      Mechanisms
      • Source kind
        first_look
        Local pointer
        /mechanism
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Not recorded
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      Future update
      Status
      pending_review
      Message
      This monograph will be updated in the future as current exact-product and claim-level review is completed.
      Source unavailable
      false
      Reason
      The historical content is restored; comprehensive contemporary verification remains incomplete.
      Historical first look: uses, mechanism, dosing context, and administration

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      droperidol
      Source IDH51-F5FF0F0213A316376433F826
      Generic name
      Droperidol
      Source IDH51-15E7DA1C5D594827AAFEDA32
      Class
      GI and antiemetic
      Source IDH51-0FC1BD15DCFE3B14DF783FC8
      Subclass
      Butyrophenone antiemetic/antipsychotic
      Source IDH51-3CD0CD90141183F65701B0FB
      Primary uses
      1. Nausea/vomiting
        Source IDH51-89ACFFE055307175DD77F084
      2. Acute agitation
        Source IDH51-E219DB11C1708A3C871FA5E4
      Mechanism
      Blocks central dopamine D2 receptors; additional receptor effects vary by agent.
      Source IDH51-130B6A4E9241D8EB2293C5C7
      Mechanism level
      drug_specific
      Source IDH51-30EB82CBF1786750A3490740
      Basic dosing orientation
      Adult | Dose depends on indication and patient risk | Dose depends on indication and patient risk | Patient- and indication-specific | See current package insert | IV push
      Source IDH51-42C8BD07143B8F60DC2A77D3
      Administration orientation
      Slow IV over 1 to 2 minutes; 2.5 mg/mL; may dilute; Slow IV over 1 to 2 minutes
      Source IDH51-6EA0B043D12E9DDAD3FA2558
      Renal and population orientation
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
      Source IDH51-18E650E515BBF8A59536735C
      Key safety orientation
      1. QT prolongation, torsades, hypotension, sedation, and extrapyramidal effects.
        Source IDH51-E43EA6903F43BC1E3C7ADC0A
      Coverage path
      structured_local_snapshot
      Source IDH51-64B60CE05898DC273B22804C
      Coverage path label
      Structured GlobalRPh route snapshot
      Source IDH51-40626A0751669819C50D0444
      Legacy title
      Droperidol
      Source IDH51-3F92C8396BC6AD28F9E72DA1
      Review note
      First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
      Source IDH51-8E494A4C60DC97FF5092B8AC
      Search text
      Droperidol GI and antiemetic Butyrophenone antiemetic/antipsychotic Nausea/vomiting Acute agitation Blocks central dopamine D2 receptors; additional receptor effects vary by agent. Adult | Dose depends on indication and patient risk | Dose depends on indication and patient risk | Patient- and indication-specific | See current package insert | IV push Slow IV over 1 to 2 minutes; 2.5 mg/mL; may dilute; Slow IV over 1 to 2 minutes Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. QT prolongation, torsades, hypotension, sedation, and extrapyramidal effects. Structured GlobalRPh route snapshot
      Source IDH51-8E66AEBDD94196D98D495908
      Official access mode
      search
      Source IDH51-13F73D7647898A4B855EE774
      Official search query
      Droperidol
      Source IDH51-A4F315FF86AEC1AEDB39F0AE
      Official access reason
      A source-backed DailyMed search is available; select and confirm the exact IV product.
      Source IDH51-242D05FB0DF2C2746F0AA5EE

      No separate structured rows were bundled for preparation, continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.

      Historical IV-push guidance

      Recovered v5.1 source content; historical, awaiting current review.

      PopulationDose scopeConcentrationRateStatusNotes
      Source IDH51-C23986E1CF9E058A0649438C
      Adult
      Source IDH51-23D40D69C2DB24C6DDD0BB46
      		Dose depends on indication and patient risk
      Source IDH51-797FD1439AB2B41A293802AA
      		2.5 mg/mL; may dilute
      Source IDH51-2ADF79FD5949373255C6D0DE
      		Slow IV over 1 to 2 minutes
      Source IDH51-93E407B66A2EA99A177134F1
      		Use only when ordered and supported by current labeling or institutional policy
      Source IDH51-D67EE09DA7D06AA33A46955B
      		Review QTc, electrolytes, interacting drugs, and local monitoring policy.
      Source IDH51-1E270688F25E42CD1DF8BA2F

      Historical indication and population dosing

      Recovered tables and source-separated snapshots; full clinical revalidation remains pending.

      Existing dose and route snapshots

      RoutePopulationIndicationDoseIntervalDurationAdministrationSource levelNotes
      Source IDH51-AD3925C8B11BA29C1D6BDAEC
      IV push
      Source IDH51-55C22AC20D675C9C1699D76E
      		Adult
      Source IDH51-4BD1804575A21769D50C3C46
      		Dose depends on indication and patient risk
      Source IDH51-D8856BB982078980E22FEA82
      		Dose depends on indication and patient risk
      Source IDH51-2D55FC71AD90DD667C0CC890
      		Patient- and indication-specific
      Source IDH51-AD7E24F50D0EC49DFD77DCAA
      		See current package insert
      Source IDH51-0501D51E19FAB568FFDA46EE
      		Slow IV over 1 to 2 minutes
      Source IDH51-A8AD39606C097074C7C840A3
      		Existing GlobalRPh IV push snapshot
      Source IDH51-74DD5AD2E5788F1EBA584D38
      		Use only when ordered and supported by current labeling or institutional policy Review QTc, electrolytes, interacting drugs, and local monitoring policy.
      Source IDH51-AC41EE1496C8D84D06D014C9

      Historical renal-function guidance

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      Classification
      current_label_review_required
      Source IDH51-2253514393F810405C9477A0
      Summary
      Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
      Source IDH51-353CBA3150A0F2251C84A493
      Method note
      Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
      Source IDH51-33616A74FCB0EA91CFE6A810

      Historical Common IV uses

      Recovered v5.1 source content; historical, awaiting current review.

      1. Nausea/vomiting
        Source IDH51-62947373DEE7075B1D4B2AE6
      2. Acute agitation
        Source IDH51-27B146A3FCAF774517E2F04E

      Historical Warnings and safeguards

      Recovered v5.1 source content; historical, awaiting current review.

      1. QT prolongation, torsades, hypotension, sedation, and extrapyramidal effects.
        Source IDH51-A0B1BB5CD8BD3B6135DA7F04

      Historical Monitoring

      Recovered v5.1 source content; historical, awaiting current review.

      1. ECG when risk factors or higher doses are present
        Source IDH51-CE7F8BAF8460740D4569ACC8
      2. Blood pressure and sedation
        Source IDH51-2F4D85473E0AF30CC44DB26A
      Other recovered source fields and original editorial metadata

      Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.

      Catalog source fields

      Id
      droperidol
      Source IDH51-6D01DC71096A9F3193592E97
      Generic name
      Droperidol
      Source IDH51-46F4E6FFA2723A1FEC37752B
      Brand names
      1. Inapsine
        Source IDH51-7A2CEEE4186E74853363A534
      Class
      GI and antiemetic
      Source IDH51-E9997C153818D733C2B01AE9
      Subclass
      Butyrophenone antiemetic/antipsychotic
      Source IDH51-F2053501D8F30182901F1A60
      Summary
      IV droperidol may be used for nausea or agitation under QT-risk and institutional monitoring policies.
      Source IDH51-DB6AC49D74270466364140E5
      Populations
      1. Adult
        Source IDH51-B1D1D8F3BE5316A4A212AB16
      Evidence tier
      IV push safety normalization - verify stocked product
      Source IDH51-594721A1E190824A8D7FCBDB
      High alert
      true
      Source IDH51-19F409A38668487D49FF8C45
      Hazardous
      false
      Source IDH51-EC526A7F487951E96A56DD4D
      Status
      Active
      Source IDH51-C3B31C5522549F165D9AA816
      Reviewed
      2026-08-29
      Source IDH51-5E770D9B5BED3AD574CA1041
      Version added
      1.2
      Source IDH51-14C315DB6658FDED3D05E1A3
      Sources
      LabelUrlKind
      Source IDH51-9BAF6FA4B8716FC822B4B467
      DailyMed label search
      Source IDH51-98DF839B42E5F3F6B46FE0D2
      		https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Droperidol (opens in a new tab)
      Source IDH51-0DE90FC1E0A4D393AEC9FD2C
      		Primary
      Source IDH51-F1E7B79EB7797B889C815334
      Source IDH51-6A83BC5ADD0DB4F436845467
      GlobalRPh legacy IV dilution monograph
      Source IDH51-754BEFE1CAC3F3F239BD3ED3
      		legacy:auto
      Source IDH51-AAE83E0DA27611676FBA742E
      		Legacy
      Source IDH51-91DC47D57837788F1CBD0FCA
      Legacy title
      Droperidol
      Source IDH51-96A2B1BE6D46BD313590B124
      Clinical release verification
      Audit version
      3.4
      Source IDH51-16DBB58E705EFDE410423E0F
      Audited on
      2026-08-30
      Source IDH51-45AC7D428242F957212A57F1
      Level
      amber
      Source IDH51-EE5EDF3F750659CBB1A6A15A
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-6C91EF1D45AB38897866CE7A
      Exact current label candidate
      false
      Source IDH51-708E58D366C9338B3006D400
      Numeric support ratio
      0
      Source IDH51-141B43FA6C45CB17BBE60467
      Reference url count
      1
      Source IDH51-4FA9DC756D1D5F81E8645AD6
      Broken reference count
      0
      Source IDH51-F8835940FCEF1D0303058DFA
      Point of use confirmation required
      true
      Source IDH51-4C071CAE632657E2DE52C1B3
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-E7FBDEA76551756E1C8CD945

      Dosing source fields

      Id
      droperidol
      Source IDH51-11A8D2F6BE197BF3DE937B52
      Generic name
      Droperidol
      Source IDH51-D307F68677C1A06DA8FF63C8
      Coverage status
      direct_official_label_access_plus_local_snapshot
      Source IDH51-EC6EA240449B04B122A75C6C
      Package insert
      Query name
      Droperidol
      Source IDH51-5515BC872AAF9541963972D3
      Product and route must match
      true
      Source IDH51-0B7B0635F433FAA69E087789
      Live current label enabled
      false
      Source IDH51-5016FE8633B92256EFCDBFA8
      Source priority
      Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
      Source IDH51-D7B13A78656F480A05CA0076
      Direct official label access enabled
      true
      Source IDH51-E59103BCC9EF651A0F6F88A1
      Outbound server request required
      false
      Source IDH51-054C89D3BAE481C3FD0D4E2D
      Local summary status
      not_bundled
      Source IDH51-4E4A134F011AF5842A2952D6
      Clinical review
      Locally normalized
      false
      Source IDH51-A9F4FB269865AB8AFDFD5C53
      Reviewed
      2026-08-29
      Source IDH51-46CCA50CBD80FC7E01A5FB67
      Status
      Direct official package-insert access enabled; indication-specific local normalization pending.
      Source IDH51-E083F1F766B5ABCEE60AE4A8
      Clinical release verification
      Audit version
      3.4
      Source IDH51-6851A6E5A135942310942369
      Audited on
      2026-08-30
      Source IDH51-19B8942DAD5197387D298686
      Level
      amber
      Source IDH51-0A4828916FCC3FF3E8051FED
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-84F4AB2EB926BE8710B8A520
      Exact current label candidate
      false
      Source IDH51-1A6660502AB0893201801BF9
      Numeric support ratio
      0
      Source IDH51-FF0EAD89B890859395DFAC64
      Reference url count
      1
      Source IDH51-3BB78D70E318BBA95C05DE7C
      Broken reference count
      0
      Source IDH51-CA3D8B5B851DAC3CAA417316
      Point of use confirmation required
      true
      Source IDH51-4CAB4B1F725E1F2ADFB89699
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-D2DED83CEEC5D5B43E896768
      Historical preparation assessment

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      droperidol
      Source IDH51-9CE8FB1F592D8356D501C4B9
      Name
      Droperidol
      Source IDH51-478B4CF645CF1F35C29B79FA
      Brands
      Inapsine
      Source IDH51-B641CB97CE03AF993E221482
      Therapeutic class
      GI and antiemetic
      Source IDH51-073D79AE789C4C2D6A733192
      Review version
      3.1
      Source IDH51-1B5AD393521A6092BAD8F5FF
      Review date
      2026-08-30
      Source IDH51-E71FF7F76FCCF5A06253F929
      Release status
      no_released_dilution_current_label_review_required
      Source IDH51-C2102D0DE916E538F411C64E
      Market status
      Status
      no_current_us_iv_spl_confirmed
      Source IDH51-7D2CC60499889386B26A60AC
      Basis
      No high-confidence current IV SPL was automatically selected; legacy information is segregated
      Source IDH51-831DAC540D52143BA3506079
      Ten point assessment
      Exact formulation
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-2BE5223683FDF372F5BB94EB
      Reconstitution concentration
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-08DAECE800A82447C91497FA
      Maximum or recommended final concentration
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-5FC2E0E5AAF0C0B281A38EF1
      Appropriate standardized containers
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-C1B19A891CA128D12616B409
      Adult dosing range
      Dose depends on indication and patient risk Dose depends on indication and patient risk
      Source IDH51-9A4D55E904A42136D9A78DA1
      Pediatric dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-18435E74BC24574ED56DA417
      Neonatal dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-B51915470ADC1B82643C92F8
      Infusion time
      Slow IV over 1 to 2 minutes
      Source IDH51-F7CCA8FD6B5F8F57B44AEAE7
      Fluid restriction alternatives
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-CFEC953BDF1F2D71B251B304
      Current manufacturer labeling
      Match confidence
      unresolved
      Source IDH51-C47B20DB952B5D5859A88A08
      Field provenance
      Exact formulation
      Primary
      not_found
      Source IDH51-E7FEDAE96CB7F9D96C0B0CF7
      Reconstitution concentration
      Primary
      not_found
      Source IDH51-588A3796061CF25E198A09FF
      Maximum or recommended final concentration
      Primary
      not_found
      Source IDH51-D54DB59E6A6665B6455B68C3
      Appropriate standardized containers
      Primary
      not_found
      Source IDH51-1281FDC8B9BD5FDF02E317BA
      Adult dosing range
      Primary
      existing_structured_record
      Source IDH51-7EF452C28F3BBFC6CE3DE42D
      Pediatric dosing range
      Primary
      not_found
      Source IDH51-67C1CC55E98DCBCD3966AA96
      Neonatal dosing range
      Primary
      not_found
      Source IDH51-EAF8BB7F589C8371BDE62CCB
      Infusion time
      Primary
      existing_structured_record
      Source IDH51-732834A283459D5C00DDE76A
      Fluid restriction alternatives
      Primary
      not_found
      Source IDH51-DE3ACF03682A7649AA1905EB
      Current manufacturer labeling
      Primary
      DailyMed search gateway
      Source IDH51-3EB8BF669BA3C8A73A982B6D
      Population applicability
      Adult
      Applicability
      supported_or_source_present
      Source IDH51-7C4DB2401E52DE153518F36C
      Guide generation allowed
      true
      Source IDH51-EDE341BD8A72BD9BA4CF6817
      Pediatric
      Applicability
      not_established
      Source IDH51-38472B2ADEA4540943A188C9
      Guide generation allowed
      false
      Source IDH51-6836897DE781B6A4C1C080D4
      Neonatal
      Applicability
      not_established
      Source IDH51-A794305AE703D0B7528F86A2
      Guide generation allowed
      false
      Source IDH51-BF5A2148D3633B4296D3E005
      Route presence
      Structured dilution
      false
      Source IDH51-74C224FFE2A06958C7F002DC
      Iv push
      true
      Source IDH51-D9590DBF3C9F1EC027DD234B
      Continuous infusion
      false
      Source IDH51-2DFFB138A34030DE8059897B
      Pediatric source
      false
      Source IDH51-A2B4D245E96C42CE1936583A
      Neonatal source
      false
      Source IDH51-352D8382C928A4D3CC20FAC3
      Legacy reference
      Status
      not_available
      Source IDH51-289076C0D8FD4206E871A325
      Label resolution
      Status
      build_environment_network_unavailable
      Source IDH51-9CAD70AC734D45CD4854C725
      Source files
      1. catalog.json
        Source IDH51-F6DAA83A3F4415764913AB36
      2. dosing.json
        Source IDH51-9D5FA71CA56FF18060113E40
      3. legacy-map.json
        Source IDH51-0336A813B261D400D18BC1BE
      4. new-in-v1.2.json
        Source IDH51-386ACD324082506C5ABC8F05
      Clinical release note
      Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
      Source IDH51-3539931FEED2551146F85072
      Historical statement IDs and source locations

      These IDs identify recovered source units. They are not evidence-qualified clinical claims.

      Historical IDOriginal source locationStatus
      H51-6D01DC71096A9F3193592E97catalog.json
      /records/87/id      		Historical; current review incomplete
      H51-46F4E6FFA2723A1FEC37752Bcatalog.json
      /records/87/generic_name      		Historical; current review incomplete
      H51-7A2CEEE4186E74853363A534catalog.json
      /records/87/brand_names/0      		Historical; current review incomplete
      H51-E9997C153818D733C2B01AE9catalog.json
      /records/87/class      		Historical; current review incomplete
      H51-F2053501D8F30182901F1A60catalog.json
      /records/87/subclass      		Historical; current review incomplete
      H51-DB6AC49D74270466364140E5catalog.json
      /records/87/summary      		Historical; current review incomplete
      H51-62947373DEE7075B1D4B2AE6catalog.json
      /records/87/common_uses/0      		Historical; current review incomplete
      H51-27B146A3FCAF774517E2F04Ecatalog.json
      /records/87/common_uses/1      		Historical; current review incomplete
      H51-C23986E1CF9E058A0649438Ccatalog.json
      /records/87/iv_push/0      		Historical; current review incomplete
      H51-23D40D69C2DB24C6DDD0BB46catalog.json
      /records/87/iv_push/0/population      		Historical; current review incomplete
      H51-797FD1439AB2B41A293802AAcatalog.json
      /records/87/iv_push/0/dose_scope      		Historical; current review incomplete
      H51-2ADF79FD5949373255C6D0DEcatalog.json
      /records/87/iv_push/0/concentration      		Historical; current review incomplete
      H51-93E407B66A2EA99A177134F1catalog.json
      /records/87/iv_push/0/rate      		Historical; current review incomplete
      H51-D67EE09DA7D06AA33A46955Bcatalog.json
      /records/87/iv_push/0/status      		Historical; current review incomplete
      H51-1E270688F25E42CD1DF8BA2Fcatalog.json
      /records/87/iv_push/0/notes      		Historical; current review incomplete
      H51-A0B1BB5CD8BD3B6135DA7F04catalog.json
      /records/87/warnings/0      		Historical; current review incomplete
      H51-CE7F8BAF8460740D4569ACC8catalog.json
      /records/87/monitoring/0      		Historical; current review incomplete
      H51-2F4D85473E0AF30CC44DB26Acatalog.json
      /records/87/monitoring/1      		Historical; current review incomplete
      H51-B1D1D8F3BE5316A4A212AB16catalog.json
      /records/87/populations/0      		Historical; current review incomplete
      H51-594721A1E190824A8D7FCBDBcatalog.json
      /records/87/evidence_tier      		Historical; current review incomplete
      H51-19F409A38668487D49FF8C45catalog.json
      /records/87/high_alert      		Historical; current review incomplete
      H51-EC526A7F487951E96A56DD4Dcatalog.json
      /records/87/hazardous      		Historical; current review incomplete
      H51-C3B31C5522549F165D9AA816catalog.json
      /records/87/status      		Historical; current review incomplete
      H51-5E770D9B5BED3AD574CA1041catalog.json
      /records/87/reviewed      		Historical; current review incomplete
      H51-14C315DB6658FDED3D05E1A3catalog.json
      /records/87/version_added      		Historical; current review incomplete
      H51-9BAF6FA4B8716FC822B4B467catalog.json
      /records/87/sources/0      		Historical; current review incomplete
      H51-98DF839B42E5F3F6B46FE0D2catalog.json
      /records/87/sources/0/label      		Historical; current review incomplete
      H51-0DE90FC1E0A4D393AEC9FD2Ccatalog.json
      /records/87/sources/0/url      		Historical; current review incomplete
      H51-F1E7B79EB7797B889C815334catalog.json
      /records/87/sources/0/kind      		Historical; current review incomplete
      H51-6A83BC5ADD0DB4F436845467catalog.json
      /records/87/sources/1      		Historical; current review incomplete
      H51-754BEFE1CAC3F3F239BD3ED3catalog.json
      /records/87/sources/1/label      		Historical; current review incomplete
      H51-AAE83E0DA27611676FBA742Ecatalog.json
      /records/87/sources/1/url      		Historical; current review incomplete
      H51-91DC47D57837788F1CBD0FCAcatalog.json
      /records/87/sources/1/kind      		Historical; current review incomplete
      H51-96A2B1BE6D46BD313590B124catalog.json
      /records/87/legacy_title      		Historical; current review incomplete
      H51-16DBB58E705EFDE410423E0Fcatalog.json
      /records/87/clinical_release_verification/audit_version      		Historical; current review incomplete
      H51-45AC7D428242F957212A57F1catalog.json
      /records/87/clinical_release_verification/audited_on      		Historical; current review incomplete
      H51-EE5EDF3F750659CBB1A6A15Acatalog.json
      /records/87/clinical_release_verification/level      		Historical; current review incomplete
      H51-6C91EF1D45AB38897866CE7Acatalog.json
      /records/87/clinical_release_verification/release_gate      		Historical; current review incomplete
      H51-708E58D366C9338B3006D400catalog.json
      /records/87/clinical_release_verification/exact_current_label_candidate      		Historical; current review incomplete
      H51-0E9F97D953FCD32EE6BCD5AAcatalog.json
      /records/87/clinical_release_verification/selected_setid      		Historical; current review incomplete
      H51-65431BC5632C2A3C7866F108catalog.json
      /records/87/clinical_release_verification/selected_label_title      		Historical; current review incomplete
      H51-141B43FA6C45CB17BBE60467catalog.json
      /records/87/clinical_release_verification/numeric_support_ratio      		Historical; current review incomplete
      H51-4FA9DC756D1D5F81E8645AD6catalog.json
      /records/87/clinical_release_verification/reference_url_count      		Historical; current review incomplete
      H51-F8835940FCEF1D0303058DFAcatalog.json
      /records/87/clinical_release_verification/broken_reference_count      		Historical; current review incomplete
      H51-4C071CAE632657E2DE52C1B3catalog.json
      /records/87/clinical_release_verification/point_of_use_confirmation_required      		Historical; current review incomplete
      H51-E7FBDEA76551756E1C8CD945catalog.json
      /records/87/clinical_release_verification/note      		Historical; current review incomplete
      H51-EF69F95E56DF60F6352F8269catalog.json
      /records/87/clinical_release_verification/dailymed_search_url      		Historical; current review incomplete
      H51-11A8D2F6BE197BF3DE937B52dosing.json
      /records/87/id      		Historical; current review incomplete
      H51-D307F68677C1A06DA8FF63C8dosing.json
      /records/87/generic_name      		Historical; current review incomplete
      H51-EC6EA240449B04B122A75C6Cdosing.json
      /records/87/coverage_status      		Historical; current review incomplete
      H51-5515BC872AAF9541963972D3dosing.json
      /records/87/package_insert/query_name      		Historical; current review incomplete
      H51-58673275D8DD1F11AA6DE4BEdosing.json
      /records/87/package_insert/preferred_setid      		Historical; current review incomplete
      H51-0B7B0635F433FAA69E087789dosing.json
      /records/87/package_insert/product_and_route_must_match      		Historical; current review incomplete
      H51-5016FE8633B92256EFCDBFA8dosing.json
      /records/87/package_insert/live_current_label_enabled      		Historical; current review incomplete
      H51-D7B13A78656F480A05CA0076dosing.json
      /records/87/package_insert/source_priority      		Historical; current review incomplete
      H51-E59103BCC9EF651A0F6F88A1dosing.json
      /records/87/package_insert/direct_official_label_access_enabled      		Historical; current review incomplete
      H51-054C89D3BAE481C3FD0D4E2Ddosing.json
      /records/87/package_insert/outbound_server_request_required      		Historical; current review incomplete
      H51-4E4A134F011AF5842A2952D6dosing.json
      /records/87/package_insert/local_summary_status      		Historical; current review incomplete
      H51-2253514393F810405C9477A0dosing.json
      /records/87/renal/classification      		Historical; current review incomplete
      H51-353CBA3150A0F2251C84A493dosing.json
      /records/87/renal/summary      		Historical; current review incomplete
      H51-33616A74FCB0EA91CFE6A810dosing.json
      /records/87/renal/method_note      		Historical; current review incomplete
      H51-AD3925C8B11BA29C1D6BDAECdosing.json
      /records/87/existing_route_snapshots/0      		Historical; current review incomplete
      H51-55C22AC20D675C9C1699D76Edosing.json
      /records/87/existing_route_snapshots/0/route      		Historical; current review incomplete
      H51-4BD1804575A21769D50C3C46dosing.json
      /records/87/existing_route_snapshots/0/population      		Historical; current review incomplete
      H51-D8856BB982078980E22FEA82dosing.json
      /records/87/existing_route_snapshots/0/indication      		Historical; current review incomplete
      H51-2D55FC71AD90DD667C0CC890dosing.json
      /records/87/existing_route_snapshots/0/dose      		Historical; current review incomplete
      H51-AD7E24F50D0EC49DFD77DCAAdosing.json
      /records/87/existing_route_snapshots/0/interval      		Historical; current review incomplete
      H51-0501D51E19FAB568FFDA46EEdosing.json
      /records/87/existing_route_snapshots/0/duration      		Historical; current review incomplete
      H51-A8AD39606C097074C7C840A3dosing.json
      /records/87/existing_route_snapshots/0/administration      		Historical; current review incomplete
      H51-74DD5AD2E5788F1EBA584D38dosing.json
      /records/87/existing_route_snapshots/0/source_level      		Historical; current review incomplete
      H51-AC41EE1496C8D84D06D014C9dosing.json
      /records/87/existing_route_snapshots/0/notes      		Historical; current review incomplete
      H51-A9F4FB269865AB8AFDFD5C53dosing.json
      /records/87/clinical_review/locally_normalized      		Historical; current review incomplete
      H51-46CCA50CBD80FC7E01A5FB67dosing.json
      /records/87/clinical_review/reviewed      		Historical; current review incomplete
      H51-E083F1F766B5ABCEE60AE4A8dosing.json
      /records/87/clinical_review/status      		Historical; current review incomplete
      H51-6851A6E5A135942310942369dosing.json
      /records/87/clinical_release_verification/audit_version      		Historical; current review incomplete
      H51-19B8942DAD5197387D298686dosing.json
      /records/87/clinical_release_verification/audited_on      		Historical; current review incomplete
      H51-0A4828916FCC3FF3E8051FEDdosing.json
      /records/87/clinical_release_verification/level      		Historical; current review incomplete
      H51-84F4AB2EB926BE8710B8A520dosing.json
      /records/87/clinical_release_verification/release_gate      		Historical; current review incomplete
      H51-1A6660502AB0893201801BF9dosing.json
      /records/87/clinical_release_verification/exact_current_label_candidate      		Historical; current review incomplete
      H51-D6025EC91EEAC0442CEEF972dosing.json
      /records/87/clinical_release_verification/selected_setid      		Historical; current review incomplete
      H51-09EB8922DC919E2DF9D7AB71dosing.json
      /records/87/clinical_release_verification/selected_label_title      		Historical; current review incomplete
      H51-FF0EAD89B890859395DFAC64dosing.json
      /records/87/clinical_release_verification/numeric_support_ratio      		Historical; current review incomplete
      H51-3BB78D70E318BBA95C05DE7Cdosing.json
      /records/87/clinical_release_verification/reference_url_count      		Historical; current review incomplete
      H51-CA3D8B5B851DAC3CAA417316dosing.json
      /records/87/clinical_release_verification/broken_reference_count      		Historical; current review incomplete
      H51-4CAB4B1F725E1F2ADFB89699dosing.json
      /records/87/clinical_release_verification/point_of_use_confirmation_required      		Historical; current review incomplete
      H51-D2DED83CEEC5D5B43E896768dosing.json
      /records/87/clinical_release_verification/note      		Historical; current review incomplete
      H51-B73E3E455A89ECECB8455B61dosing.json
      /records/87/clinical_release_verification/dailymed_search_url      		Historical; current review incomplete
      H51-F5FF0F0213A316376433F826first-look-v5.1.json
      /records/87/id      		Historical; current review incomplete
      H51-15E7DA1C5D594827AAFEDA32first-look-v5.1.json
      /records/87/generic_name      		Historical; current review incomplete
      H51-0FC1BD15DCFE3B14DF783FC8first-look-v5.1.json
      /records/87/class      		Historical; current review incomplete
      H51-3CD0CD90141183F65701B0FBfirst-look-v5.1.json
      /records/87/subclass      		Historical; current review incomplete
      H51-89ACFFE055307175DD77F084first-look-v5.1.json
      /records/87/primary_uses/0      		Historical; current review incomplete
      H51-E219DB11C1708A3C871FA5E4first-look-v5.1.json
      /records/87/primary_uses/1      		Historical; current review incomplete
      H51-130B6A4E9241D8EB2293C5C7first-look-v5.1.json
      /records/87/mechanism      		Historical; current review incomplete
      H51-30EB82CBF1786750A3490740first-look-v5.1.json
      /records/87/mechanism_level      		Historical; current review incomplete
      H51-42C8BD07143B8F60DC2A77D3first-look-v5.1.json
      /records/87/basic_dosing_orientation      		Historical; current review incomplete
      H51-6EA0B043D12E9DDAD3FA2558first-look-v5.1.json
      /records/87/administration_orientation      		Historical; current review incomplete
      H51-18E650E515BBF8A59536735Cfirst-look-v5.1.json
      /records/87/renal_and_population_orientation      		Historical; current review incomplete
      H51-E43EA6903F43BC1E3C7ADC0Afirst-look-v5.1.json
      /records/87/key_safety_orientation/0      		Historical; current review incomplete
      H51-64B60CE05898DC273B22804Cfirst-look-v5.1.json
      /records/87/coverage_path      		Historical; current review incomplete
      H51-40626A0751669819C50D0444first-look-v5.1.json
      /records/87/coverage_path_label      		Historical; current review incomplete
      H51-5DEF20FAEAB38E0FBEEF6E9Afirst-look-v5.1.json
      /records/87/official_label_url      		Historical; current review incomplete
      H51-3F92C8396BC6AD28F9E72DA1first-look-v5.1.json
      /records/87/legacy_title      		Historical; current review incomplete
      H51-8E494A4C60DC97FF5092B8ACfirst-look-v5.1.json
      /records/87/review_note      		Historical; current review incomplete
      H51-8E66AEBDD94196D98D495908first-look-v5.1.json
      /records/87/search_text      		Historical; current review incomplete
      H51-8C347BCFB08D0A51C2BE9D0Dfirst-look-v5.1.json
      /records/87/official_search_url      		Historical; current review incomplete
      H51-13F73D7647898A4B855EE774first-look-v5.1.json
      /records/87/official_access_mode      		Historical; current review incomplete
      H51-AFCE9E5CC17B116915547A9Afirst-look-v5.1.json
      /records/87/official_access_url      		Historical; current review incomplete
      H51-A4F315FF86AEC1AEDB39F0AEfirst-look-v5.1.json
      /records/87/official_search_query      		Historical; current review incomplete
      H51-242D05FB0DF2C2746F0AA5EEfirst-look-v5.1.json
      /records/87/official_access_reason      		Historical; current review incomplete
      H51-9CE8FB1F592D8356D501C4B9preparation-assessments-v3.8.json
      /87/id      		Historical; current review incomplete
      H51-478B4CF645CF1F35C29B79FApreparation-assessments-v3.8.json
      /87/name      		Historical; current review incomplete
      H51-B641CB97CE03AF993E221482preparation-assessments-v3.8.json
      /87/brands      		Historical; current review incomplete
      H51-073D79AE789C4C2D6A733192preparation-assessments-v3.8.json
      /87/therapeutic_class      		Historical; current review incomplete
      H51-1B5AD393521A6092BAD8F5FFpreparation-assessments-v3.8.json
      /87/review_version      		Historical; current review incomplete
      H51-E71FF7F76FCCF5A06253F929preparation-assessments-v3.8.json
      /87/review_date      		Historical; current review incomplete
      H51-C2102D0DE916E538F411C64Epreparation-assessments-v3.8.json
      /87/release_status      		Historical; current review incomplete
      H51-7D2CC60499889386B26A60ACpreparation-assessments-v3.8.json
      /87/market_status/status      		Historical; current review incomplete
      H51-831DAC540D52143BA3506079preparation-assessments-v3.8.json
      /87/market_status/basis      		Historical; current review incomplete
      H51-2BE5223683FDF372F5BB94EBpreparation-assessments-v3.8.json
      /87/ten_point_assessment/exact_formulation      		Historical; current review incomplete
      H51-08DAECE800A82447C91497FApreparation-assessments-v3.8.json
      /87/ten_point_assessment/reconstitution_concentration      		Historical; current review incomplete
      H51-5FC2E0E5AAF0C0B281A38EF1preparation-assessments-v3.8.json
      /87/ten_point_assessment/maximum_or_recommended_final_concentration      		Historical; current review incomplete
      H51-C1B19A891CA128D12616B409preparation-assessments-v3.8.json
      /87/ten_point_assessment/appropriate_standardized_containers      		Historical; current review incomplete
      H51-9A4D55E904A42136D9A78DA1preparation-assessments-v3.8.json
      /87/ten_point_assessment/adult_dosing_range      		Historical; current review incomplete
      H51-18435E74BC24574ED56DA417preparation-assessments-v3.8.json
      /87/ten_point_assessment/pediatric_dosing_range      		Historical; current review incomplete
      H51-B51915470ADC1B82643C92F8preparation-assessments-v3.8.json
      /87/ten_point_assessment/neonatal_dosing_range      		Historical; current review incomplete
      H51-F7CCA8FD6B5F8F57B44AEAE7preparation-assessments-v3.8.json
      /87/ten_point_assessment/infusion_time      		Historical; current review incomplete
      H51-CFEC953BDF1F2D71B251B304preparation-assessments-v3.8.json
      /87/ten_point_assessment/fluid_restriction_alternatives      		Historical; current review incomplete
      H51-5BB350F6E155AB0A6C438ECBpreparation-assessments-v3.8.json
      /87/ten_point_assessment/current_manufacturer_labeling/setid      		Historical; current review incomplete
      H51-CA8F2EBCD88A6736A4341B80preparation-assessments-v3.8.json
      /87/ten_point_assessment/current_manufacturer_labeling/title      		Historical; current review incomplete
      H51-3B1C5C4BFD0D9A91FE1700C8preparation-assessments-v3.8.json
      /87/ten_point_assessment/current_manufacturer_labeling/published_date      		Historical; current review incomplete
      H51-003EC9F2853BA50B0A9C8668preparation-assessments-v3.8.json
      /87/ten_point_assessment/current_manufacturer_labeling/manufacturer      		Historical; current review incomplete
      H51-C47B20DB952B5D5859A88A08preparation-assessments-v3.8.json
      /87/ten_point_assessment/current_manufacturer_labeling/match_confidence      		Historical; current review incomplete
      H51-E0ABF1B83FD11C58732D4175preparation-assessments-v3.8.json
      /87/ten_point_assessment/current_manufacturer_labeling/url      		Historical; current review incomplete
      H51-E7FEDAE96CB7F9D96C0B0CF7preparation-assessments-v3.8.json
      /87/field_provenance/exact_formulation/primary      		Historical; current review incomplete
      H51-588A3796061CF25E198A09FFpreparation-assessments-v3.8.json
      /87/field_provenance/reconstitution_concentration/primary      		Historical; current review incomplete
      H51-D54DB59E6A6665B6455B68C3preparation-assessments-v3.8.json
      /87/field_provenance/maximum_or_recommended_final_concentration/primary      		Historical; current review incomplete
      H51-1281FDC8B9BD5FDF02E317BApreparation-assessments-v3.8.json
      /87/field_provenance/appropriate_standardized_containers/primary      		Historical; current review incomplete
      H51-7EF452C28F3BBFC6CE3DE42Dpreparation-assessments-v3.8.json
      /87/field_provenance/adult_dosing_range/primary      		Historical; current review incomplete
      H51-67C1CC55E98DCBCD3966AA96preparation-assessments-v3.8.json
      /87/field_provenance/pediatric_dosing_range/primary      		Historical; current review incomplete
      H51-EAF8BB7F589C8371BDE62CCBpreparation-assessments-v3.8.json
      /87/field_provenance/neonatal_dosing_range/primary      		Historical; current review incomplete
      H51-732834A283459D5C00DDE76Apreparation-assessments-v3.8.json
      /87/field_provenance/infusion_time/primary      		Historical; current review incomplete
      H51-DE3ACF03682A7649AA1905EBpreparation-assessments-v3.8.json
      /87/field_provenance/fluid_restriction_alternatives/primary      		Historical; current review incomplete
      H51-3EB8BF669BA3C8A73A982B6Dpreparation-assessments-v3.8.json
      /87/field_provenance/current_manufacturer_labeling/primary      		Historical; current review incomplete
      H51-7C4DB2401E52DE153518F36Cpreparation-assessments-v3.8.json
      /87/population_applicability/adult/applicability      		Historical; current review incomplete
      H51-EDE341BD8A72BD9BA4CF6817preparation-assessments-v3.8.json
      /87/population_applicability/adult/guide_generation_allowed      		Historical; current review incomplete
      H51-38472B2ADEA4540943A188C9preparation-assessments-v3.8.json
      /87/population_applicability/pediatric/applicability      		Historical; current review incomplete
      H51-6836897DE781B6A4C1C080D4preparation-assessments-v3.8.json
      /87/population_applicability/pediatric/guide_generation_allowed      		Historical; current review incomplete
      H51-A794305AE703D0B7528F86A2preparation-assessments-v3.8.json
      /87/population_applicability/neonatal/applicability      		Historical; current review incomplete
      H51-BF5A2148D3633B4296D3E005preparation-assessments-v3.8.json
      /87/population_applicability/neonatal/guide_generation_allowed      		Historical; current review incomplete
      H51-74C224FFE2A06958C7F002DCpreparation-assessments-v3.8.json
      /87/route_presence/structured_dilution      		Historical; current review incomplete
      H51-D9590DBF3C9F1EC027DD234Bpreparation-assessments-v3.8.json
      /87/route_presence/iv_push      		Historical; current review incomplete
      H51-2DFFB138A34030DE8059897Bpreparation-assessments-v3.8.json
      /87/route_presence/continuous_infusion      		Historical; current review incomplete
      H51-A2B4D245E96C42CE1936583Apreparation-assessments-v3.8.json
      /87/route_presence/pediatric_source      		Historical; current review incomplete
      H51-352D8382C928A4D3CC20FAC3preparation-assessments-v3.8.json
      /87/route_presence/neonatal_source      		Historical; current review incomplete
      H51-289076C0D8FD4206E871A325preparation-assessments-v3.8.json
      /87/legacy_reference/status      		Historical; current review incomplete
      H51-9CAD70AC734D45CD4854C725preparation-assessments-v3.8.json
      /87/label_resolution/status      		Historical; current review incomplete
      H51-F6DAA83A3F4415764913AB36preparation-assessments-v3.8.json
      /87/source_files/0      		Historical; current review incomplete
      H51-9D5FA71CA56FF18060113E40preparation-assessments-v3.8.json
      /87/source_files/1      		Historical; current review incomplete
      H51-0336A813B261D400D18BC1BEpreparation-assessments-v3.8.json
      /87/source_files/2      		Historical; current review incomplete
      H51-386ACD324082506C5ABC8F05preparation-assessments-v3.8.json
      /87/source_files/3      		Historical; current review incomplete
      H51-3539931FEED2551146F85072preparation-assessments-v3.8.json
      /87/clinical_release_note      		Historical; current review incomplete

      Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)

      All medicationsReturn to medication headingApplication top